Wird geladen...
Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study
Background/Aim: Chronic myeloid leukaemia (CML) rarely affects the paediatric population and has an incidence of 0.06-0.12/100,000 children per year. The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy. Patients and Methods: Our coho...
Gespeichert in:
| Veröffentlicht in: | In Vivo |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
International Institute of Anticancer Research
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559902/ https://ncbi.nlm.nih.gov/pubmed/31028210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11552 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|